Literature DB >> 10485554

Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.

E K Akpek1, I Ahmed, F H Hochberg, M Soheilian, T P Dryja, F A Jakobiec, C S Foster.   

Abstract

OBJECTIVE: To analyze the clinical features, laboratory investigations, and diagnosis of intraocular-central nervous system (CNS) lymphoma in a cohort of patients who underwent diagnostic vitrectomy.
DESIGN: Retrospective case series. METHOD AND STUDY MATERIALS: Thirty-four vitreous biopsy specimens obtained from 26 patients with treatment-resistant or unusual uveitis were re-evaluated in a masked fashion. The specimens were classified into three groups: "negative," "suspicious of malignancy," and "positive" based on the cytologic features, immunomarkers, and flow cytometry. The medical records of the patients were reviewed retrospectively. MAIN OUTCOME MEASURES: The reliability of vitreous cytology in diagnosing intraocular-CNS lymphoma and the differences in clinical features of patients with intraocular-CNS lymphoma and uveitis.
RESULTS: The two ocular pathologists concurred in their criteria for interpretation of all specimens. There was 100% concordance between the cytologic reports read independently by the two ocular pathologists over the 5-year period and the read-out done in a masked fashion at the time of the study. Ten patients were diagnosed with intraocular-CNS lymphoma based on the vitreous cytology and clinical features. The time interval between the initial presentation and vitreous biopsy was 1 week to 2 years, with 80% of the patients diagnosed within the first year. Retinal involvement in the form of lymphomatous subretinal pigment epithelial infiltrates, vasculitis, and apparent retinochoroiditis was present in six cases. Initial neuroimaging studies revealed concomitant CNS involvement in three patients, and an additional three developed CNS lymphoma following diagnosis by vitreous biopsy. Patients were treated with radiotherapy, chemotherapy, or both. Two of the four patients with a follow-up of greater than 12 months died due to CNS involvement.
CONCLUSIONS: Vitreous cytology is a sensitive, reliable, and reproducible method of diagnosing intraocular-CNS lymphoma. A high index of suspicion based on the clinical findings and course of the uveitis is critically important in decision-making for diagnostic vitrectomy. Central nervous system involvement is frequent and associated with a high mortality rate. Ophthalmology 1999;106:1805-1810

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485554     DOI: 10.1016/S0161-6420(99)90341-X

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  38 in total

1.  Ataxia and vision loss: flow cytometric diagnosis of primary central nervous system lymphoma.

Authors:  Mark T Cahill; Mirela Stancu; Jorge G Arroyo
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  Uveitis and neurologic diseases: an often overlooked relationship.

Authors:  Saskia M Maca; Martina Scharitzer; Talin Barisani-Asenbauer
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

3.  Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.

Authors:  Dana J Wallace; DeFen Shen; George F Reed; Masaru Miyanaga; Manabu Mochizuki; H Nida Sen; Samuel S Dahr; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  Anterior chamber paracentesis cytology (cytospin technique) for the diagnosis of intraocular lymphoma.

Authors:  P T Finger; C Papp; P Latkany; M Kurli; C E Iacob
Journal:  Br J Ophthalmol       Date:  2006-02-17       Impact factor: 4.638

5.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

6.  Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.

Authors:  Takako Ito; Atsunobu Takeda; Kohta Fujiwara; Eiichi Hasegawa; Shintaro Nakao; Yoshihiro Ohishi; Yoshinao Oda; Hiroshi Yoshikawa; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-13       Impact factor: 3.117

7.  Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience.

Authors:  Alexandra Stefanovic; Janet Davis; Timothy Murray; Arnold Markoe; Izidore S Lossos
Journal:  Br J Haematol       Date:  2010-07-12       Impact factor: 6.998

Review 8.  Intraocular lymphoma.

Authors:  Li-Juan Tang; Chang-Lin Gu; Ping Zhang
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  Eradication of tumor colonization and invasion by a B cell-specific immunotoxin in a murine model for human primary intraocular lymphoma.

Authors:  Zhuqing Li; Sankaranarayana P Mahesh; De Fen Shen; Baoying Liu; Willie O Siu; Frank S Hwang; Qing-Chen Wang; Chi-Chao Chan; Ira Pastan; Robert B Nussenblatt
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

10.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.